What Researchers Did
Researchers investigated the effect of hyperbaric oxygenation (HBO) on the clinical course and complications in 124 patients during the acute stage of ischemic stroke, comparing them to a control group.
What They Found
Hyperbaric oxygenation (HBO) temporarily reduced the depth of unconsciousness and motor and aphasic disorders during sessions in 124 patients. HBO significantly reduced the frequency of condition aggravation in the first week and prevented recurrent cerebral circulatory disorders, also decreasing complications like pneumonia and pulmonary edema. While the number of patients showing neurological symptom regression was similar, the regression was more pronounced in those receiving HBO.
What This Means for Canadian Patients
Canadian patients experiencing acute ischemic stroke might potentially benefit from hyperbaric oxygenation (HBO) to reduce early complications and the severity of certain neurological deficits. However, given the short-lived effects on some symptoms and similar overall rates of neurological regression, HBO may serve as an adjunctive therapy rather than a primary treatment.
Canadian Relevance
This study has no direct Canadian connection or specific relevance to the Canadian healthcare system.
Study Limitations
The abstract indicates that the beneficial effects of hyperbaric oxygenation on some neurological symptoms were often short-lived, and overall neurological regression rates were similar between groups.